NovoCure (NVCR) Free Cash Flow (2014 - 2026)
NovoCure (NVCR) posted Free Cash Flow of $1.2 million for Q2 2026, up 106.51% sequentially from -$18.7 million in Q1 2026, and up 105.68% YoY from $591220.0 in Q2 2025.
NovoCure (NVCR) Free Cash Flow (2014 - 2026) Analysis & Trends
NovoCure has reported Free Cash Flow for 13 years, with the latest figure at $1.2 million in Q2 2026.
- Quarterly Free Cash Flow rose 105.68% year-over-year to $1.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$25.4 million (up 68.36% YoY) and the FY2025 annual result came in at -$75.7 million, down 9.32% from the prior year.
- Free Cash Flow advanced to $1.2 million in Q2 2026 per NVCR's latest filing, from -$18.7 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $16.7 million in Q3 2022 and troughed at -$46.3 million in Q1 2025.
- A 5-year average of -$14.1 million and a median of -$15.9 million in 2024 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow tumbled 7898.46% in 2022, then soared 4959.61% in 2025.
- Over 5 years, Free Cash Flow stood at -$10.1 million in 2022, then plunged by 110.88% to -$21.4 million in 2023, then surged by 42.03% to -$12.4 million in 2024, then plunged by 84.78% to -$22.9 million in 2025, then jumped by 105.31% to $1.2 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $1.2 million, -$18.7 million, and -$22.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 279.60 Mn |
| 10 | NovoCure | 1.99 Bn | 1.55 Bn | 142.48 Mn | 1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 Mn |
| Jun 30, 2026 | 1.22 Mn |
| Mar 31, 2026 | -18.67 Mn |
| Mar 31, 2026 | -18.67 Mn |
| Dec 31, 2025 | -22.90 Mn |
| Dec 31, 2025 | -22.90 Mn |
| Sep 30, 2025 | 14.92 Mn |
| Sep 30, 2025 | 14.92 Mn |
| Jun 30, 2025 | -21.42 Mn |
| Jun 30, 2025 | -21.42 Mn |
| Mar 31, 2025 | -46.28 Mn |
| Mar 31, 2025 | -46.28 Mn |
| Dec 31, 2024 | -12.39 Mn |
| Dec 31, 2024 | -12.39 Mn |
| Sep 30, 2024 | -307,000.00 |
| Sep 30, 2024 | -307,000.00 |
| Jun 30, 2024 | -13.17 Mn |
| Jun 30, 2024 | -13.17 Mn |
| Mar 31, 2024 | -43.36 Mn |
| Mar 31, 2024 | -43.36 Mn |